- Vical to Receive up to $130 Million in Upfront and Development Milestones Plus Double-digit Royalties – Vical to Conduct Conference Call and Webcast at 8:00 a.m. ET Friday July 15th SAN DIEGO & TOKYO—July 14, 2011—Vical Incorporated (Nasdaq: VICL)…
See more ›
Blog Archives
Vical and Astellas Announce $130 million Worldwide License Agreements for TransVax™ Cytomegalovirus Vaccine
Biovista Inc. Receives Prestigious EU Grant to use its Drug Repositioning Platform for Personalized Medicine
CHARLOTTESVILLE, Virginia and ATHENS, Greece, May 5, 2011 /French Bio Beach/ — Biovista Inc. announced yesterday that it’s EU affiliate has been awarded a prestigious grant worth $0.5 million, for research and development in the area of personalized medicine. The…
See more ›
6th Annual French American Competition for Innovative Entrepreneurs
Win transatlantic mentoring and networking support from YEi as well as the opportunity to go to France meet potential partners BOSTON – October 7, 2010 – Retis is pleased to launch the 2011 “Young Entrepreneurs Initiative” (YEi) competition for innovative…
See more ›
Posted in Latests News and Alerts, Press Releases
Sanford-Burnham Pairs with MEDIT SA to Design Smarter Drugs
Sanford-Burnham Pairs with MEDIT SA to Design Smarter Drugs.
Powerful new software matches aberrant proteins with compounds that could fix them.
See more ›
SD News: Sanofi-aventis To Acquire TargeGen, Inc.
Source: http://www.targegen.com/news063010.htm San Diego, CA – June 30, 2010- TargeGen, Inc., a privately held biotechnology company focused on the development of small molecule kinase inhibitors today announced that the Company has agreed to be acquired by sanofi-aventis (EURONEXT: SAN; NYSE:…
See more ›
One in four firms not complying with chemical legislation
Inspection data suggests that a quarter of chemical companies have not been complying with European chemicals legislation.
See more ›
Marie Curie International Research Staff Exchange Scheme (IRSES)
The Marie Curie International Research Staff Exchange Scheme in the People program of FP7 aims at strengthening research partnership through short staff exchanges and networking between European research organizations and organizations in Third Countries (such as the United States). This…
See more ›
French BioBeach facilitates a strategic alliance between Sanofi-Aventis and the Salk Institute
It all started a year ago when Sanofi-aventis sponsored a French BioBeach event presenting Lyon Biopole to the San Diego biotech community. Stephane Richard had then
See more ›
Stephane Richard is now part of the French Foreign Trade Advisors network
On April 1st, Stephane was officially appointed French Foreign Trade Advisor by the French Minister of Foreign Trade. Stephane
See more ›
Newsletter
Facebook
LinkedIn
Twitter
Picasa
Flickr
YouTube
